Mitchell; et al. (1997). "The Exosome: A Conserved Eukaryotic RNA Processing Complex Containing Multiple 3′→5′ Exoribonucleases". Cell91 (4): 457–466. PMID9390555. doi:10.1016/S0092-8674(00)80432-8.
Allmang; et al. (1999). "The yeast exosome and human PM-Scl are related complexes of 3'→ 5' exonucleases". Genes and Development13 (16): 2148–58. PMID10465791. doi:10.1101/gad.13.16.2148.
Brouwer; et al. (2001). "Three novel components of the human exosome". Journal of Biological Chemistry276: 6177–84. PMID11110791. doi:10.1074/jbc.M007603200.
Koonin; et al. (2001). "Prediction of the archaeal exosome and its connections with the proteasome and the translation and transcription machineries by a comparative-genomic approach". Genome Research11 (2): 240–52. PMID11157787. doi:10.1101/gr.162001.
Evguenieva-Hackenberg; et al. (2003). "An exosome-like complex in Sulfolobus solfataricus". EMBO Reports4 (9): 889–93. PMID12947419. doi:10.1038/sj.embor.embor929.
Schilders; et al. (2006). "Cell and molecular biology of the exosome: how to make or break an RNA". International review of cytology251: 159–208. PMID16939780. doi:10.1016/S0074-7696(06)51005-8.
Lorentzen; et al. (2005). "The archaeal exosome core is a hexameric ring structure with three catalytic subunits". Nature Structural & Molecular Biology12: 575–81. PMID15951817. doi:10.1038/nsmb952.
Raijmakers; et al. (2002). "Protein-protein interactions between human exosome components support the assembly of RNase PH-type subunits into a six-membered PNPase-like ring". Journal of Molecular Biology323: 653–63. PMID12419256. doi:10.1016/S0022-2836(02)00947-6.
Walter; et al. (2006). "Characterization of native and reconstituted exosome complexes from the hyperthermophilic archaeon Sulfolobus solfataricus". Molecular Microbiology62: 1076–89. PMID17078816. doi:10.1111/j.1365-2958.2006.05393.x.
Ishii; et al. (2003). "Crystal structure of the tRNA processing enzyme RNase PH from Aquifex aeolicus". Journal of Biological Chemistry278: 32397–404. PMID12746447. doi:10.1074/jbc.M300639200.
Symmons; et al. (2000). "A duplicated fold is the structural basis for polynucleotide phosphorylase catalytic activity, processivity, and regulation". Structure8: 1215–26. PMID11080643. doi:10.1016/S0969-2126(00)00521-9.
Lin-Chao; et al. (2007). "The PNPase, exosome and RNA helicases as the building components of evolutionarily-conserved RNA degradation machines". Journal of Biomedical Science14: 523–32. doi:10.1007/s11373-007-9178-y.
Harlow; et al. (2004). "Crystal structure of the phosphorolytic exoribonuclease RNase PH from Bacillus subtilis and implications for its quaternary structure and tRNA binding". Protein Science13: 668–77. PMID14767080. doi:10.1110/ps.03477004.
Schneider; et al. (2007). "The exosome subunit Rrp44 plays a direct role in RNA substrate recognition". Molecular Cell27: 324–31. PMID17643380. doi:10.1016/j.molcel.2007.06.006.
Mian; et al. (1997). "Comparative sequence analysis of ribonucleases HII, III, II PH and D". Nucleic Acids Research25: 3187–3195. PMID9241229. doi:10.1093/nar/25.16.3187.
Raijmakers; et al. (2004). "The exosome, a molecular machine for controlled RNA degradation in both nucleus and cytoplasm". European Journal of Cell Biology83: 175–83. PMID15346807. doi:10.1078/0171-9335-00385.
Wang; et al. (2005). "Domain interactions within the Ski2/3/8 complex and between the Ski complex and Ski7p". RNA11: 1291–302. PMID16043509. doi:10.1261/rna.2060405.
LaCava; et al. (2005). "RNA degradation by the exosome is promoted by a nuclear polyadenylation complex". Cell121: 713–24. PMID15935758. doi:10.1016/j.cell.2005.04.029.
Dziembowski; et al. (2007). "A single subunit, Dis3, is essentially responsible for yeast exosome core activity". Nature Structural & Molecular Biology14: 15–22. PMID17173052. doi:10.1038/nsmb1184.
Lorentzen; et al. (2005). "Structural basis of 3' end RNA recognition and exoribonucleolytic cleavage by an exosome RNase PH core". Molecular Cell20: 473–81. PMID16285928. doi:10.1016/j.molcel.2005.10.020.
LeJeune; et al. (2003). "Nonsense-mediated mRNA decay in mammalian cells involves decapping, deadenylating, and exonucleolytic activities". Molecular Cell12: 675–87. PMID14527413. doi:10.1016/S1097-2765(03)00349-6.
Lin; et al. (2007). "Localization of AU-rich element-containing mRNA in cytoplasmic granules containing exosome subunits". Journal of Biological Chemistry282: 19958–68. PMID17470429. doi:10.1074/jbc.M702281200.
Allmang; et al. (1999). "Functions of the exosome in rRNA, snoRNA and snRNA synthesis". EMBO Journal18: 5399–410. PMID10508172. doi:10.1093/emboj/18.19.5399.
Schilders; et al. (2005). "MPP6 is an exosome-associated RNA-binding protein involved in 5.8S rRNA maturation". Nucleic Acids Research33: 6795–804. PMID16396833. doi:10.1093/nar/gki982.
van Dijk; et al. (2007). "Human cell growth requires a functional cytoplasmic exosome, which is involved in various mRNA decay pathways". RNA13: 1027–35. PMID17545563. doi:10.1261/rna.575107.
Targoff; et al. (1985). "Nucleolar localization of the PM-Scl antigen". Arthritis & Rheumatism28: 226–30. PMID3918546. doi:10.1002/art.1780280221.
Raijmakers; et al. (2004). "PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome". Arthritis & Rheumatism50: 565–9. PMID14872500. doi:10.1002/art.20056.
Brouwer; et al. (2002). "Autoantibodies directed to novel components of the PM/Scl complex, the human exosome.". Arthritis Research4: 134–8. PMID11879549. doi:10.1186/ar389.
Schilders; et al. (2007). "C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome". Arthritis & Rheumatism56: 2449–54. PMID17599775. doi:10.1002/art.22710.
Mahler; et al. (2005). "Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen". Arthritis Research & Therapy7: R704–13. PMID15899056. doi:10.1186/ar1729.
Mahler; et al. (2007). "Novel aspects of autoantibodies to the PM/Scl complex: Clinical, genetic and diagnostic insights". Autoimmunity Reviews6: 432–7. PMID17643929. doi:10.1016/j.autrev.2007.01.013.
Jablonska; et al. (1998). "Scleromyositis: a scleroderma/polymyositis overlap syndrome". Clinical Rheumatology17: 465–7. PMID9890673. doi:10.1007/BF01451281.
Lum; et al. (2004). "Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes". Cell116: 121–37. PMID14718172. doi:10.1016/S0092-8674(03)01035-3.
Mitchell; et al. (1997). "The Exosome: A Conserved Eukaryotic RNA Processing Complex Containing Multiple 3′→5′ Exoribonucleases". Cell91 (4): 457–466. PMID9390555. doi:10.1016/S0092-8674(00)80432-8.
Allmang; et al. (1999). "The yeast exosome and human PM-Scl are related complexes of 3'→ 5' exonucleases". Genes and Development13 (16): 2148–58. PMID10465791. doi:10.1101/gad.13.16.2148.
Brouwer; et al. (2001). "Three novel components of the human exosome". Journal of Biological Chemistry276: 6177–84. PMID11110791. doi:10.1074/jbc.M007603200.
Koonin; et al. (2001). "Prediction of the archaeal exosome and its connections with the proteasome and the translation and transcription machineries by a comparative-genomic approach". Genome Research11 (2): 240–52. PMID11157787. doi:10.1101/gr.162001.
Evguenieva-Hackenberg; et al. (2003). "An exosome-like complex in Sulfolobus solfataricus". EMBO Reports4 (9): 889–93. PMID12947419. doi:10.1038/sj.embor.embor929.
Schilders; et al. (2006). "Cell and molecular biology of the exosome: how to make or break an RNA". International review of cytology251: 159–208. PMID16939780. doi:10.1016/S0074-7696(06)51005-8.
Lorentzen; et al. (2005). "The archaeal exosome core is a hexameric ring structure with three catalytic subunits". Nature Structural & Molecular Biology12: 575–81. PMID15951817. doi:10.1038/nsmb952.
Raijmakers; et al. (2002). "Protein-protein interactions between human exosome components support the assembly of RNase PH-type subunits into a six-membered PNPase-like ring". Journal of Molecular Biology323: 653–63. PMID12419256. doi:10.1016/S0022-2836(02)00947-6.
Walter; et al. (2006). "Characterization of native and reconstituted exosome complexes from the hyperthermophilic archaeon Sulfolobus solfataricus". Molecular Microbiology62: 1076–89. PMID17078816. doi:10.1111/j.1365-2958.2006.05393.x.
Ishii; et al. (2003). "Crystal structure of the tRNA processing enzyme RNase PH from Aquifex aeolicus". Journal of Biological Chemistry278: 32397–404. PMID12746447. doi:10.1074/jbc.M300639200.
Symmons; et al. (2000). "A duplicated fold is the structural basis for polynucleotide phosphorylase catalytic activity, processivity, and regulation". Structure8: 1215–26. PMID11080643. doi:10.1016/S0969-2126(00)00521-9.
Harlow; et al. (2004). "Crystal structure of the phosphorolytic exoribonuclease RNase PH from Bacillus subtilis and implications for its quaternary structure and tRNA binding". Protein Science13: 668–77. PMID14767080. doi:10.1110/ps.03477004.
Schneider; et al. (2007). "The exosome subunit Rrp44 plays a direct role in RNA substrate recognition". Molecular Cell27: 324–31. PMID17643380. doi:10.1016/j.molcel.2007.06.006.
Mian; et al. (1997). "Comparative sequence analysis of ribonucleases HII, III, II PH and D". Nucleic Acids Research25: 3187–3195. PMID9241229. doi:10.1093/nar/25.16.3187.
Raijmakers; et al. (2004). "The exosome, a molecular machine for controlled RNA degradation in both nucleus and cytoplasm". European Journal of Cell Biology83: 175–83. PMID15346807. doi:10.1078/0171-9335-00385.
Wang; et al. (2005). "Domain interactions within the Ski2/3/8 complex and between the Ski complex and Ski7p". RNA11: 1291–302. PMID16043509. doi:10.1261/rna.2060405.
LaCava; et al. (2005). "RNA degradation by the exosome is promoted by a nuclear polyadenylation complex". Cell121: 713–24. PMID15935758. doi:10.1016/j.cell.2005.04.029.
Dziembowski; et al. (2007). "A single subunit, Dis3, is essentially responsible for yeast exosome core activity". Nature Structural & Molecular Biology14: 15–22. PMID17173052. doi:10.1038/nsmb1184.
Lorentzen; et al. (2005). "Structural basis of 3' end RNA recognition and exoribonucleolytic cleavage by an exosome RNase PH core". Molecular Cell20: 473–81. PMID16285928. doi:10.1016/j.molcel.2005.10.020.
LeJeune; et al. (2003). "Nonsense-mediated mRNA decay in mammalian cells involves decapping, deadenylating, and exonucleolytic activities". Molecular Cell12: 675–87. PMID14527413. doi:10.1016/S1097-2765(03)00349-6.
Lin; et al. (2007). "Localization of AU-rich element-containing mRNA in cytoplasmic granules containing exosome subunits". Journal of Biological Chemistry282: 19958–68. PMID17470429. doi:10.1074/jbc.M702281200.
Allmang; et al. (1999). "Functions of the exosome in rRNA, snoRNA and snRNA synthesis". EMBO Journal18: 5399–410. PMID10508172. doi:10.1093/emboj/18.19.5399.
Schilders; et al. (2005). "MPP6 is an exosome-associated RNA-binding protein involved in 5.8S rRNA maturation". Nucleic Acids Research33: 6795–804. PMID16396833. doi:10.1093/nar/gki982.
van Dijk; et al. (2007). "Human cell growth requires a functional cytoplasmic exosome, which is involved in various mRNA decay pathways". RNA13: 1027–35. PMID17545563. doi:10.1261/rna.575107.
Gelpi; et al. (1991). "Identification of protein components reactive with anti-PM/Scl autoantibodies". Clinical and Experimental Immunology81: 59–64. PMID2199097.
Targoff; et al. (1985). "Nucleolar localization of the PM-Scl antigen". Arthritis & Rheumatism28: 226–30. PMID3918546. doi:10.1002/art.1780280221.
Raijmakers; et al. (2004). "PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome". Arthritis & Rheumatism50: 565–9. PMID14872500. doi:10.1002/art.20056.
Brouwer; et al. (2002). "Autoantibodies directed to novel components of the PM/Scl complex, the human exosome.". Arthritis Research4: 134–8. PMID11879549. doi:10.1186/ar389.
Schilders; et al. (2007). "C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome". Arthritis & Rheumatism56: 2449–54. PMID17599775. doi:10.1002/art.22710.
Mahler; et al. (2005). "Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen". Arthritis Research & Therapy7: R704–13. PMID15899056. doi:10.1186/ar1729.
Mahler; et al. (2007). "Novel aspects of autoantibodies to the PM/Scl complex: Clinical, genetic and diagnostic insights". Autoimmunity Reviews6: 432–7. PMID17643929. doi:10.1016/j.autrev.2007.01.013.
Jablonska; et al. (1998). "Scleromyositis: a scleroderma/polymyositis overlap syndrome". Clinical Rheumatology17: 465–7. PMID9890673. doi:10.1007/BF01451281.
Lum; et al. (2004). "Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes". Cell116: 121–37. PMID14718172. doi:10.1016/S0092-8674(03)01035-3.
